跳至主要内容
临床试验/NCT02769650
NCT02769650已完成不适用

Clinical Significance of Stress-MRI Evaluation of Right Coronary Artery Chronic Total Occlusion Recanalization Efficacy in Patients With Coronary Artery Disease.

Meshalkin Research Institute of Pathology of Circulation1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2010年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
72
试验地点
1
主要终点
Stress-MRI evaluation

研究概览

简要总结

The hypothesis of this study is that Stress-MRI is a clinically significant method of myocardial perfusion assessment after coronary angioplasty with stenting of right coronary artery (RCA) chronic total occlusion (CTO) is performed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stable angina, CCS FC II-IV
  • "Right-dominance" coronary circulation according to coronary angiography
  • Absence of other significant atherosclerotic coronary lesions (more than 65%)
  • High risk of myocardium ischemia according to stress-MRI data (perfusion defect in 2 or more segments in the area of interest)
  • Signed, documented informed consent prior to admission to the study

排除标准

  • Acute coronary syndrome
  • Contraindications for adenosine stress test
  • Low and moderate risk of myocardium ischemia according to stress-MRI data (perfusion defect in less than 2 segments in the area of interest)

研究组 & 干预措施

Stress-MRI + Chronic total occlusion PCI

Experimental

Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Coronary angioplasty with stenting of RCA CTO

干预措施: CTO coronary angioplasty (Procedure)

Stress-MRI + Chronic total occlusion PCI

Experimental

Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Coronary angioplasty with stenting of RCA CTO

干预措施: Stress-MRI (Procedure)

Stress-MRI + Optimal medicamentous treatment

Active Comparator

Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Optimal medicamentous treatment

干预措施: Optimal medicamentous treatment (Drug)

Stress-MRI + Optimal medicamentous treatment

Active Comparator

Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Optimal medicamentous treatment

干预措施: Stress-MRI (Procedure)

结局指标

主要结局

Stress-MRI evaluation

时间窗: Within 2 and 12 month after hospitalization

High risk of myocardium ischemia according to stress-MRI data (perfusion defect in 2 or more segments in the area of interest)

次要结局

  • Major adverse cardiac and cerebrovascular events (MACCE)(During 1 year after first stress-MRI assessment)
  • Stress-MRI evaluation (2)(Within 2 and 12 month after hospitalization)
  • Clinical assessment(Within 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 moths after hospitalization)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验